By Peet Serfontein & Motheo Tlhagale
We enter a long position. Our upside target is set at R13.35. We recommend a stop-loss at R11.20.
Life Healthcare Group Holdings Ltd is a leading South African private healthcare provider. The group operates a broad network of acute hospitals and complementary healthcare services, including mental health facilities, rehabilitation, renal dialysis and diagnostic services. Its business model is centred on providing specialised, high-quality healthcare through modern facilities, skilled medical professionals and partnerships with doctors and medical schemes.
Following the disposal of its international diagnostic-imaging operations, Life Molecular Imaging (LMI), Life Healthcare has increased its focus on its Southern African operations, operational efficiency, clinical quality and sustainable growth across the region. Fundamentally, we view Life Healthcare as a solid player within the healthcare space, and we expect healthy elective surgery demand to remain supportive of volumes and margins.
Technically, the strong volume support near the current price supports a bullish outlook, as the share is trading close to a high-volume trading zone that has historically attracted significant investor interest (see the insert on the main chart). This concentration of volume suggests that the area may act as a strong support base, helping to absorb selling pressure and limit downside risk.
The price is also within the accumulation phase of the Wyckoff Price Cycle which supports the bullish outlook, suggesting that selling pressure is being absorbed while stronger buyers gradually build positions. This base-building process often precedes a transition into the mark-up phase.
We suggest a medium capital at-risk allocation to this trade. Increase exposure for a break above R12.
Share performance
Share Information
| Share Code | LHC |
| Industry | Health Care Equipment & Service |
| Market Capital (ZAR) | 17.4 billion |
| One-Year Total Return | 11.28% |
| Return Year-to-date | 6.50% |
| Current Price (ZAR) | 11.86 |
| 52-Week High (ZAR) | 13.02 |
| 52-Week Low (ZAR) | 10.00 |
| Financial Year End | September |
| Life Healthcare has a beta of 0.8, meaning it is generally less volatile than the broader market and tends to be more defensive during periods of market uncertainty. | |
Consensus Expectations (Bloomberg)
| FY25 | FY26E | FY27E | FY28E | |
|---|---|---|---|---|
| Headline Earnings per Share (ZAR) | 0.99 | 1.17 | 1.27 | 1.39 |
| Growth (%) | 17.73 | 9.00 | 8.88 | |
| Dividend Per Share (ZAR) | 0.56 | 0.63 | 0.69 | 0.73 |
| Growth (%) | 12.14 | 9.08 | 6.28 | |
| Forward PE (times) | 10.16 | 9.32 | 8.56 | |
| Forward Dividend Yield (%) | 5.30 | 5.78 | 6.14 | |
| Strong earnings growth is expected over the forecast period, supported by sustained dividend growth. | ||||
Buy/sell rationale
Technical analysis
Long-term fundamental view
Update on previous trade ideas
| Share Name and position | Entry | Current Price | Movement | Comment | Time to exit |
|---|---|---|---|---|---|
| DSY SA - Close position (Stop-loss) | 262.16 | 246.88 | -5.8% | The share triggered our stop-loss, prompting us to close the position. | 9 November 2026 |
| HAR SA - Close position (Profit-take) | 268.22 | 375.91 | +40.1% | The share reached our profit target and we closed the position. | 5 October 2026 |
| CML SA - Buy (Continue to hold) | 43.21 | 43.80 | +1.4% | The evolving price action remains of interest, with Elliott Wave analysis suggesting that Wave 5 may be developing as the share tests its 200-day simple moving average (SMA). Positive momentum supports the trade idea. We maintain our profit target at R49.80 with a trailing stop-loss at R42.60. | 26 October 2026 |
| SSW SA - Buy (Continue to hold) | 43.49 | 50.28 | +15.6% | The breakout from the falling wedge pattern remains of interest, although the share is still trading just below its 200-day SMA. Positive momentum supports the trade idea. We maintain our profit target at R56.80 with a trailing stop-loss at R48.00. | 12 October 2026 |
| INL SA - Buy (Continue to hold) | 135.08 | 140.94 | +4.3% | The developing ascending triangle pattern remains of interest, with the share continuing to trade above its 200-day SMA. Upside momentum has regained strength, supporting the trade idea. We maintain our profit target at R153.00 with a trailing stop-loss at R137.00. | 21 September 2026 |
| SLM SA - Buy (Continue to hold) | 86.81 | 87.05 | +0.3% | The price action remains of interest, with Elliott Wave analysis suggesting that Wave B may be starting. However, the share remains below its 200-day SMA, while persistent downside momentum remains a concern. We maintain our profit target at R98.00 with a trailing stop-loss at R84.70. | 27 September 2026 |
| BTI SA - Buy (Continue to hold) | 976.99 | 903.49 | -7.5% | The developing bullish pennant remains of interest, although the share has crossed below its 200-day SMA and strong downside momentum is a concern. We maintain our profit target at R1 202.00 with a trailing stop-loss at R861.00. | 4 November 2026 |
